ALFA Finder| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 0.0 | 0.0 | 0.0 |
| Total income | 0.0 | 0.0 | 0.0 |
| Profit before exceptional items & tax | -0.4 | -0.2 | -0.2 |
| Profit before tax | -0.4 | -0.2 | -0.2 |
| Net profit | -0.4 | -0.2 | -0.3 |
| Operating margin | 0.0% | 0.0% | 0.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
BSE results filing, BSE: 531686. Figures extracted from the filing.
Advik Laboratories Ltd: key numbers
- Share price
- ₹2.08
- Market cap
- ₹3.98 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹-1.02 Cr
- P/E (TTM)
- -3.8×Sector 43.8×
- Promoter holding
- 35.89%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Advik Laboratories Ltd
All →MPS Pharma Board Meeting Date
MPS Pharmaa will hold a board meeting on 13 November 2026. The meeting will consider unaudited standalone results for the half year ended September 2026.
Advik Laboratories Other Announcement
MPS Pharmaa Limited filed its quarterly statement of investor complaints for the quarter ended 30th September, 2026, reporting NIL complaints.
MPS Pharma Management Change
MPS Pharmaa Limited announced the appointment of Anchal Goyal as an Independent Director for a five-year term. The company also re-appointed Ram Niwas Sharma and statutory auditors Nemani Garg Agarwal & Co.
Advik Laboratories Annual General Meeting
MPS Pharmaa Limited held its 32nd Annual General Meeting on September 29, 2026. Shareholders transacted business including the adoption of audited financial statements and director appointments.
Advik Laboratories Other Announcement
MPS Pharmaa Limited announced the availability of its FY 2025-26 Annual Report on its website. It also requested shareholders to update their KYC and PAN details.
Advik Laboratories Annual General Meeting
The company submitted its 32nd Annual Report and AGM notice for FY 2025-26. The meeting is scheduled for September 29, 2026.